Áttétes emlőrák: vizsgálatok itt: Svájc
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peoplePhase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Where
- Aarau, Basel
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Relay Therapeutics, Inc.
See details and how to joinNCT06982521 · EU 2025-523083-21-00 - 3. fázisTaking peopleA Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Where
- Baden, Basel, Lausanne, Lucerne
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06790693 · EU 2024-516162-11-00 - 3. fázisTaking peopleA Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Where
- Basel, Liestal, Rennaz
- Életkor
- 18 év to 130 év
- People
- 150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07647328 - 3. fázisTaking peopleA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Where
- Basel, Thun, Zurich
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06312176 · EU 2023-504918-29-00 - No phaseTaking peopleDESTINY Breast Respond HER2-(Ultra)Low Europe
- Where
- Baden, Frauenfeld, Fribourg, Geneva, La Chaux-de-Fonds, Lausanne, Liestal, Sankt Gallen, Sion, Zurich
- Életkor
- 18 év and over
- People
- 2295 worldwide
- Run by
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
See details and how to joinNCT05945732 - No phaseTaking peopleAURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
- Where
- Baden, Bern, Chur, Lucerne
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Jules Bordet Institute
See details and how to joinNCT02102165 - 2. fázisNot yet taking people in SvájcScreening for Brain Metastases
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 180
- Run by
- University of Zurich
See details and how to joinNCT07492121 - 4. fázisTaking peopleCombination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
- Where
- Brig, Sankt Gallen
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Prof. Wolfgang Janni
See details and how to joinNCT05362760 · EU 2024-511209-49-00